Philip P Boudreau

EVP AND CFO

Philip P Boudreau (EVP AND CFO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Abbott Laboratories (ABT). Across 1 priced purchase filing, the average 21-session return was -4.2% from execution and -5.4% from disclosure (delay-adjusted; derived). The largest single filing was $201K of ABT (2,200 sh × $91.50, as filed), executed Apr 23.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-4.2%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-5.4%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$201K

shares × price, as filed

Last traded

Apr 23

Filed Apr 27

Median ADV $1.4B across their filed names

Open performance→

Volume by month

Buys $201K Sells $747K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

ABT

Abbott Laboratories ABT · 1 buy · 1 sell 2 filings

Recent filings

ABTPURCHASE Abbott Laboratories View filing → $201K
2,200 sh × $91.50
Exec Apr 23
Filed Apr 27 · 5:34 PM ET ABTSALE Abbott Laboratories View filing → $747K
5,550 sh × $134.55
Exec Aug 8 2025
Filed Aug 11 2025 · 5:30 PM ET